Canada spends roughly the same amount per person on healthcare as Australia, France and Denmark. On the OECD’s harmonized comparison, Canada comes in at USD 7,301 per person. Australia is at USD 7,469, France at USD 7,367 and Denmark at USD 7,071.

Here is what that money buys. Canada has 2.7 practising doctors per 1,000 people. Denmark has about 4.5 and Australia about 4.2. Canada has roughly 26 CT, MRI and PET scanners per million people, about half the OECD average of 51. Denmark has about 49, and the OECD ranks Australia second for CT scanners per capita. And when the OECD measured satisfaction with the availability of quality healthcare in its 2025 edition, about 50% of Canadians said they were satisfied. In Denmark, the figure was 86%.

Canada is on track to spend about CAD 399 billion on healthcare in 2025, according to the Canadian Institute for Health Information. So what, exactly, are Canadians getting for that money?

Ask most Canadians what makes their system special and the answer will involve one thing: nobody hands you a five-figure hospital bill after a heart attack, a cancer operation or a complicated childbirth. That is not trivial. It is one of the country’s real achievements, and it is a big reason medicare is treated as close to sacred.

But it answers a different question. Being protected from the bill is one virtue. Getting a family doctor, a specialist appointment, a scan or a new hip in reasonable time is another. Standing up against the best universal systems in the world is a third. I looked at that third question separately in What Does World-Class Health Care Actually Look Like?, comparing the structures and trade-offs in several high-performing systems around the world. Canada performs strongly on the first, struggles on much of the second, and produces a mixed picture on the third.

That is the argument here. It is not an attack on medicare, and it is not a pitch for American-style healthcare. Canadian debate has a habit of treating universal coverage, Canada’s particular way of delivering care, and healthcare quality as though they were one thing. They are three, and the evidence gets more interesting once you pull them apart.

What Canadians Mean When They Say “Healthcare”

Canada does not have a national health service. It has thirteen provincial and territorial systems operating inside a federal framework, and they differ more than most Canadians realize. CIHI’s 2025 forecast has total health spending per person at CAD 9,045 in Ontario and CAD 11,617 in Nova Scotia.

Ottawa’s main lever is money. Under the Canada Health Act, provinces receive their full federal health transfer only if their plans meet five criteria: public administration, comprehensiveness, universality, portability and accessibility. The Act also penalizes extra-billing and user charges by deducting them from federal transfers dollar for dollar.

The federal government announced CAD 196.1 billion over ten years for provinces and territories under its 2023 healthcare agreement, including CAD 46.2 billion in new funding. Provinces do nearly everything else. They run the insurance plans — OHIP, RAMQ, MSP and their counterparts — negotiate physician fee schedules, fund hospitals, and decide on capital projects, operating-room capacity and scanner purchases.

Delivery is where the picture turns out to be less “government-run” than people assume. Hospitals are mostly public or not-for-profit corporations, not federal facilities. Most physicians are not government employees. They are independent practitioners paid by the province, mostly fee-for-service, with a growing share on capitation, blended or salaried models. Laboratories, pharmacies, imaging clinics, physiotherapists and many surgical clinics are privately owned. Britain’s NHS, by contrast, owns most of its hospitals and employs most of its hospital doctors.

Health Canada itself makes the distinction explicit: private providers can deliver insured healthcare services, provided patients are not charged for medically necessary insured care.

So Canada has public financing of core services and a mixed model of delivery. Those are different things, and Canadian debate blurs them constantly.

What Medicare Actually Covers

The core is medically necessary hospital and physician care with no charge at the point of service: hospital stays, emergency treatment, surgery, hospital diagnostics and doctor visits.

The list of what sits outside that core is longer than many people expect. Outpatient prescription drugs are covered through a patchwork of provincial plans and private insurance. Dental care is mostly private. Eye exams are generally insured only for particular groups, with coverage varying by province. Physiotherapy, psychology and chiropractic are largely private. Ambulance charges apply in many provinces. Long-term care accommodation can carry substantial charges, home-care availability is limited, and devices, fertility treatment and private or semi-private hospital rooms are only partly covered or not covered, depending on the province and circumstances.

Those coverage gaps are also part of the reason some Canadians look beyond the domestic system entirely, which I cover in Medical Tourism for Canadians.

Two recent federal programs have started to shift some of that. The Canadian Dental Care Plan covers eligible residents without access to private dental insurance whose adjusted family net income is under CAD 90,000. By April 2026, Health Canada said more than 6.5 million Canadians were covered and more than 4 million had already received care. Federal program statistics updated to August 31, 2026 put the cumulative number of enrolled members who had used their coverage since launch at 4,830,986.

National pharmacare has also begun operating through bilateral agreements. The federal government’s current pharmacare agreements page lists four jurisdictions — British Columbia, Manitoba, Prince Edward Island and Yukon — with agreements covering a range of contraception and diabetes medications and related products.

These are real steps. They have not closed the gaps. Most adult dental care outside CDCP eligibility, many outpatient drugs, and much psychological and allied care are still paid for by employer plans or households.

Which brings up a number that surprises people who think of Canadian healthcare as entirely government-funded. CIHI expects about 71% of 2025 health spending to be publicly funded. Roughly 29% is private, mostly households and insurers paying for exactly the things medicare leaves out.

[CHART: Public versus private share of Canadian healthcare spending, 71% / 29% (CIHI 2025)]

The CAD 399 Billion Question

CIHI projects total Canadian health spending of about CAD 399 billion in 2025. That works out to roughly CAD 9,626 per person, or 12.7% of GDP, with spending growing about 4.2% over the year.

The OECD’s numbers look different because they are built differently. CIHI reports a domestic measure in Canadian dollars. The OECD applies a standardized accounting framework and adjusts for purchasing power so countries can be compared on the same footing. Its 2024 estimate puts Canada at 11.3% of GDP and USD 7,301 per person in purchasing-power-adjusted dollars, against an OECD average of USD 5,967. The two sets of figures are not in conflict. They are answering slightly different questions in different currencies and years.

What matters is where Canada sits in the OECD’s Health at a Glance 2025 comparison. Switzerland, Norway, Germany and the Netherlands spend considerably more, roughly USD 8,400 to USD 10,000 per person, and Sweden a little more, at about USD 7,900. Australia at USD 7,469 and France at USD 7,367 are a whisker above Canada, and Denmark at USD 7,071 a whisker below. The United States is off in its own galaxy at USD 14,885.

Canada is not a low-spending healthcare country, so the blanket claim that it simply underfunds healthcare runs into these numbers. It is not one of the costliest systems on earth either. It is a mid-to-upper spender among wealthy countries, which is exactly what makes the access numbers awkward.

[CHART: Healthcare spending per person, Canada versus peer countries (OECD, USD PPP, 2024)]

What Canada Does Genuinely Well

Start with the thing Canadians are proudest of, because it deserves the pride. If you have a heart attack, need emergency surgery, go into labour or get a cancer diagnosis in Canada, you will generally leave hospital without a catastrophic bill, and nobody checked your insurance before treating you. That is an enormous advantage, and it is the core of what medicare promises.

The outcome data are also respectable. According to the OECD’s Canada country note, life expectancy is 81.7 years, against an OECD average of 81.1. Treatable mortality, meaning deaths from conditions that timely and effective care should prevent, is 58 per 100,000 people, against an OECD average of 77. Preventable mortality is 126 per 100,000, against 145.

In the Commonwealth Fund’s Mirror, Mirror 2024 comparison of 10 high-income countries, Canada ranked fourth on health outcomes and fourth on care process, which covers prevention, safety, coordination and patient engagement.

A caution belongs here. Outcomes reflect income, smoking, obesity, drug use, housing and Indigenous health disparities as much as they reflect hospitals. Canada’s low daily smoking rate — 8.7% against an OECD average of 14.8% — and comparatively high prevention spending help its numbers. Its obesity rate — 24% against 19% — works the other way. Credit or blame for outcomes does not belong to the healthcare system alone.

Some acute pathways also work well. CIHI’s 2024 wait-time data showed 94% of patients beginning radiation therapy within the 28-day benchmark. CIHI’s newer 2025 indicator reports a median wait of 13 days and a 90th-percentile wait of 22 days.

The OECD country note also puts 30-day mortality after a heart attack at 4.5% in Canada against an OECD average of 6.5%, and after stroke at 7.6% against 7.7%, although the OECD flags limitations in how Canada’s data are linked.

Canada does not have poor medicine. The system’s weakness is not necessarily what happens once the right patient reaches the right clinical team. It is often getting the patient there.

Then there is the American benchmark, which deserves a fair hearing and then a move on. The United States spends USD 14,885 per person, 17.2% of GDP. Its life expectancy is 78.4 years and its treatable mortality is 95 per 100,000. It ranked last overall in the Commonwealth Fund comparison. Canada delivers better population outcomes at about half the cost, with far stronger protection against medical bills.

But so does every other wealthy universal system. Beating the United States on financial protection does not establish that Canada has one of the best systems in the world.

The United States also has substantially more diagnostic equipment capacity: the OECD places it near the top among member countries for MRI and PET equipment per capita, while Canada has about half the OECD average for CT, MRI and PET equipment combined.

The Real Problem Is Getting In

In the Commonwealth Fund’s 2023 survey, 86% of Canadian adults said they had a regular doctor or place of care, the lowest of the 10 countries surveyed.

Timeliness looked worse. In that same survey, only 26% of Canadian adults were able to get a same- or next-day appointment the last time they were sick or needed medical attention, against a Commonwealth Fund average of 42%, again the lowest of the 10 countries.

A separate and more recent measure asks a different question. Among adults who had consulted a health provider for a non-urgent primary-care need in the previous 12 months, only 26.8% reported same-day or next-day access in 2024, according to Statistics Canada survey data published by CIHI.

The two figures come from different surveys with different questions and denominators, and they should not be read as one statistic.

The absolute numbers are larger than the percentages suggest. The OurCare 2025 survey, led by Unity Health Toronto and released with the Canadian Medical Association, estimates that 5.9 million adults lack regular primary care, down from 6.5 million in 2022. Access also follows income. In that survey, 84.9% of people earning CAD 200,000 or more had a regular clinician, against 69.6% of people earning under CAD 20,000.

Primary care is the front door of the system, and when the door jams, pressure builds elsewhere. CIHI has found that 15% of emergency-department visits are for conditions that could potentially be managed in primary care. Problems found late, chronic conditions managed loosely and prevention that never happens all sit downstream of the same shortage.

Resist the temptation to blame one cause. CIHI data show that growth in the number of family physicians slowed from about 2.7% a year in 2015 to 2017 to about 1.0% a year in 2021 to 2023, while Canada’s population grew roughly 3% in each of 2023 and 2024.

Beyond that, the usual suspects all have some support. Fee-for-service payment can discourage some forms of team-based and longitudinal care, which is one reason provinces such as Ontario and British Columbia are moving toward blended and capitation models. Administrative burden can reduce the time physicians have available for clinical practice. Residency capacity depends heavily on provincial funding, and internationally trained physicians face licensing and residency barriers.

Each factor matters. Nobody has cleanly ranked them.

Among the ten wealthy countries in the Commonwealth Fund survey, however, Canada was last on the regular-provider measure and on the reported same-/next-day appointment measure.

[CHART: Share of adults with a regular primary-care provider, Canada versus nine peer countries (Commonwealth Fund 2023)]

Waiting Is Part of the System

Imagine you need a hip replacement. The pan-Canadian benchmark is 26 weeks from the decision to operate.

According to CIHI’s 2025 wait-time report using 2024 data, about 68% of hip replacements met that benchmark, along with about 61% of knee replacements and 69% of cataract surgeries, whose benchmark is 112 days.

The detail worth noticing is that hip and knee results remain below 2019 levels even though the system performed 26% more hip replacements and 21% more knee replacements than it did then. Hospitals are doing considerably more and still not catching up. Median waits for most cancer surgeries also increased by one to five days between 2019 and 2024.

Statistics Canada’s 2024 data on specialist waits show that about 35% of people seeing a specialist for the first time waited under a month, 30% waited one to three months, and 36% waited three months or more.

The emergency department is where these pressures collide. In 2024 to 2025, CIHI counted about 16.1 million ED visits. Half of patients spent four hours or less in the department, but 1 in 10 spent more than 14 hours, up 28% from 2018 to 2019. Among patients admitted to hospital, 1 in 10 waited almost two days or more for a bed. CIHI ties the longer stays to more complex patients and delays in admission, which points to problems outside the ED itself.

For some patients, long waits turn the healthcare question into a time-versus-money decision: whether to remain in the Canadian queue or pay for medical care abroad.

Then there is the number everyone has seen. The Fraser Institute’s Waiting Your Turn reports a median wait of 28.6 weeks from GP referral to treatment in 2025, versus 9.3 weeks in 1993.

Treat it carefully. The Fraser Institute is a market-oriented think tank, and this figure comes from a survey of physicians estimating their patients’ waits, not from administrative records, and response rates in such surveys are a fair concern. It is better read as one estimate of the scale and long-run direction of waiting than as a precise administrative measurement.

The broader direction, though, is also visible in CIHI, Statistics Canada and Commonwealth Fund data, none of which depend on the Fraser Institute. On the Commonwealth Fund’s overall access domain, Canada ranked seventh of ten.

[CHART: CIHI benchmark performance for hip, knee and cataract surgery, 2019 versus 2024]

Canada Has a Capacity Problem, But Not the Simple One

The capacity numbers are lean. Canada has 2.5 hospital beds per 1,000 people, against an OECD average of 4.2. It has 2.7 practising doctors per 1,000, against 3.9. It has about 26 CT, MRI and PET scanners per million people, against an OECD average of 51.

By comparison, Australia has 4.2 doctors per 1,000 and one of the OECD’s highest levels of CT scanner availability, while Germany has roughly three times Canada’s hospital beds per capita.

Before concluding that Canada just needs more beds, consider Denmark, the Netherlands, the United Kingdom and Sweden. Denmark has 2.3 beds per 1,000, and the other three are in roughly the same low range. Countries can operate with relatively few hospital beds when primary care, home care, long-term care, discharge processes and other parts of the system keep patient flow moving.

Canada combines relatively few beds with high occupancy and pressure elsewhere in the system. Beds per 1,000 have fallen dramatically over the past several decades, and the Canadian Medical Association has reported occupancy of roughly 88% in medium and large hospitals before the pandemic.

Add patients who no longer need acute care but cannot leave because appropriate long-term care, rehabilitation or home-care arrangements are unavailable; a primary-care shortage that pushes some patients toward emergency departments; and long queues for scans and surgery.

That problem becomes much more tangible at the family level when you look at the actual choices and costs around home care for aging parents.

The OECD counts 3.7 long-term-care workers per 100 people aged 65 and over in Canada, against an OECD average of 5.0.

No single statistic captures the problem. The combination does.

[CHART: Hospital beds per 1,000 people, Canada versus peers (OECD 2025)]

[CHART: CT, MRI and PET scanners per million people, Canada versus peers (OECD 2025)]

Why “Just Spend More” Is an Incomplete Answer

Here is the question that should sit at the centre of the debate. Why does Canada spend about what Australia, France and Denmark spend, and yet have fewer physicians than those countries and weaker performance on several access measures?

One possibility is price. If Canadian physician and hospital labour, capital and other inputs are relatively expensive, the same amount of spending buys fewer people, machines or procedures. But spending comparisons alone cannot identify how much of Canada’s relative performance comes from prices and how much comes from organization and productivity.

Beyond price, several structural explanations have evidence behind them to varying degrees.

The clearest pressures are workforce and patient flow. The gap in physicians and diagnostic equipment is documented by the OECD, while ED and hospital data show the consequences when patients cannot move efficiently into and out of appropriate care settings.

Payment models may also matter. Traditional fee-for-service rewards individual billable encounters more directly than continuity, coordination or some forms of team-based care, which is one reason provinces have experimented with blended, capitation and team-based models.

Traditional global hospital budgets can also provide weaker marginal incentives to increase case volumes than activity-based approaches. Provinces have experimented with alternatives. Alberta, for example, began implementing a patient-focused funding model in 2026, while Ontario has long used volume- and case-based funding for selected procedures.

Funded operating hours, staffing availability and scope-of-practice rules also affect how much physical capacity the system can actually use. Thirteen separate provincial and territorial systems meanwhile mean different licensing arrangements, referral processes, payment rules and still-incomplete interoperability of digital health records.

Then there are claims that are harder to establish.

Some argue that letting patients buy duplicate private insurance would shorten public waits. The trial judge in the Cambie case, after reviewing extensive evidence, was not persuaded that the proposed parallel system would necessarily improve the public system.

Others argue that any expansion of private delivery necessarily drains the public system. Ontario shows how contested that proposition is. The Canadian Centre for Policy Alternatives, a left-leaning think tank, has reported that median MRI waits in Ontario rose as the province expanded private delivery. Ontario says its community surgical and diagnostic centres add large volumes of publicly funded diagnostic and surgical capacity. Those observations alone do not establish that the private-centre expansion caused either the increase or any reduction in wait times.

Money matters. So do workforce, incentives, capacity and organization. International spending comparisons do not support treating total spending alone as a sufficient explanation.

The Comparison Canadians Should Be Making

There is no universally accepted list of the world’s best healthcare systems. Different rankings reward different things. The Commonwealth Fund weighs access, care process, administrative efficiency, equity and outcomes across 10 countries, and leaves out Denmark, Norway and Japan. OECD dashboards are unweighted and explicitly are not a single performance ranking. Satisfaction surveys capture expectations as well as performance.

Canada looks comparatively strong on some outcome and care-process measures and weak on several measures of access.

In Mirror, Mirror 2024, Canada placed seventh overall among the 10 countries studied, fourth on outcomes, fourth on care process, fifth on administrative efficiency, and seventh on access and equity.

That is a useful picture, but it is only one picture. Five systems are particularly useful to compare with Canada, not as a definitive top-five list but because each illustrates a different model.

The Netherlands requires people who live or work in the country to hold standard health insurance from competing private insurers, which must accept applicants for the standard package. This is a heavily regulated market, not a free-for-all: participation is mandatory, the package is standardized and insurers are supported by risk equalization. Adults generally face a mandatory annual excess of EUR 385 in 2026, while GP visits are exempt from that excess. Most hospitals are private not-for-profits.

It ranked first on access in the Commonwealth Fund comparison, and satisfaction with the availability of quality care is above 80%. Cost barriers created by deductibles and cost sharing are one of the model’s trade-offs.

The lesson is structural: universal healthcare does not require a government insurance monopoly.

Australia runs a tax-funded Medicare system alongside a large private sector: public hospitals, private hospitals and private insurance, with duplicate private coverage permitted. According to the Australian Prudential Regulation Authority, 12.8 million people — about 46% of the population — held private hospital treatment cover at the end of June 2026.

Australia ranked first overall, first on equity and first on outcomes in the Commonwealth Fund’s 2024 study, but ninth of ten on access. A large parallel private sector therefore does not eliminate access problems.

The lesson is that a universal public system can coexist with a large parallel private sector, but the design of that combination still matters.

Switzerland requires residents to obtain regulated basic insurance from private nonprofit insurers, with income-based subsidies, deductibles and coinsurance. It sits near the top of OECD measures for satisfaction with the availability of quality care and has substantially more physicians and nurses per capita than Canada. It also spends close to USD 10,000 per person.

The trade-off is obvious: high capacity and broad patient choice come with very high costs.

Norway is predominantly tax-funded, with regional health authorities and a regular-GP scheme. It has substantially more physicians and nurses per capita than Canada and also spends more than USD 9,000 per person.

Its relevance for Canada is that strong performance does not require a large private insurance sector. A predominantly public model can also deliver high capacity when primary-care attachment and workforce supply are strong.

Denmark is tax-funded and regionally run, with GP gatekeeping, strong national health-data infrastructure and a relatively centralized hospital system. It has also used patient-choice rules allowing treatment elsewhere, including at private hospitals, when public waits exceed specified limits.

Denmark spends USD 7,071 per person, about USD 230 less than Canada, yet has 4.5 practising doctors per 1,000 peopleagainst Canada’s 2.7, 49 CT/MRI/PET units per million against Canada’s 26, and 86% satisfaction with the availability of quality care against Canada’s 50%. It operates with only 2.3 hospital beds per 1,000 people, fewer than Canada.

That makes Denmark particularly interesting. Its results suggest that low bed numbers and tax financing alone do not explain Canada’s access problems.

France and Germany also belong in the comparison. France combines statutory public insurance with near-universal complementary coverage and extensive private delivery. Germany has far more hospital beds per capita than Canada and roughly nine in ten residents covered through competing statutory sickness funds.

Here is the uncomfortable point. Canada’s treatable mortality of 58 per 100,000 is well below the OECD average. But several countries that also guarantee universal access achieve better results on important measures of access, capacity or outcomes, often with more patient choice and sometimes for similar levels of spending.

Canada’s problem is therefore not that universal healthcare is intrinsically incompatible with good access. Internationally, universal systems are organized in many different ways.

For a closer look at those alternatives — including Switzerland, the Netherlands, Australia, Japan and Taiwan — see What Does World-Class Health Care Actually Look Like?.

[CHART: Canada versus Denmark, Australia and the Netherlands on key metrics: spending, doctors, scanners, satisfaction]

[CHART: Commonwealth Fund 2024 rankings by domain: access, care process, administrative efficiency, equity, outcomes]

[CHART: Treatable mortality per 100,000 people, Canada versus peers (OECD 2025)]

The Canadian Misunderstanding About “Private Healthcare”

Universal healthcare is not the opposite of private healthcare.

To see why, separate six ideas that Canadian conversation tends to lump together.

Universal access means everyone is covered for a defined package of care. Single-payer financing means one public body pays for covered services. Public insurance means government operates the insurance system. Private insurance means private organizations provide some or all insurance coverage. Public delivery means government owns or operates healthcare providers. Private delivery means non-government organizations or practitioners provide the care.

Canada mixes these.

It has universal access to core medically necessary services, provincial single-payer financing for most insured hospital and physician care, private insurance for many services outside medicare, and delivery that includes public and not-for-profit hospitals alongside private physicians, laboratories and clinics.

What is unusual is a narrower feature: Canada and its provinces place strong restrictions on direct private payment and, in many jurisdictions, duplicate private insurance for physician and hospital services already insured by the public plan.

Health Canada now states this plainly. The Canada Health Act does not prohibit private providers from delivering insured services, provided patients are not charged for medically necessary insured care.

Other universal systems handle financing differently. The Netherlands and Switzerland rely heavily on regulated private insurers. Germany funds most residents through competing statutory sickness funds, while a minority use private insurance. France’s statutory insurance sits alongside complementary insurers, and some doctors can charge fees above the statutory tariff. Australia allows private hospital insurance on top of Medicare. Denmark and Sweden are tax-funded systems that nonetheless use private providers.

All of them maintain universal or near-universal entitlement to core healthcare.

The claim that universal healthcare inherently requires exclusive government delivery or a complete prohibition on private insurance does not fit the international evidence.

More private involvement is not the same thing as the United States. The American system differs because it lacks the same universal entitlement and exposes patients to much greater financial risk.

The opposite mistake is just as available. Private participation is not a cure for Canadian waiting times. Australia has one of the larger private sectors among the systems discussed here and still ranked ninth on access in the Commonwealth Fund study.

Workforce diversion is also a legitimate policy concern. Quebec’s Bill 83, adopted in April 2025, introduced a requirement that newly licensed physicians accumulate five years of participation in the public plan before becoming non-participating physicians. The province also tightened the process for leaving the public plan, in part because of concern about physician movement into private practice.

Which suggests that Canadians are often collapsing three separate questions into one.

Should everyone have access to healthcare regardless of ability to pay?

Who should finance that care?

And who should deliver it, under what competitive and regulatory structure?

International systems answer those questions in very different ways.

How Much Private Healthcare Already Exists in Canada?

Quite a lot, in three different senses.

First, roughly 29% of total Canadian health spending is private. Canadians already pay privately, either directly or through insurance, for substantial amounts of prescription drugs, dental care, vision care, physiotherapy, psychology, cosmetic procedures, executive health services and other uninsured care.

Second, privately owned providers deliver a great deal of publicly funded healthcare. Physicians, laboratories, pharmacies and many imaging and surgical clinics operate privately while billing provincial insurance plans. The patient may never receive a bill.

Third, governments are increasingly purchasing publicly funded procedures from independently operated clinics.

Ontario, for example, announced CAD 155 million for additional community surgical and diagnostic centres intended to expand MRI, CT and gastrointestinal endoscopy capacity. It later announced CAD 125 million for additional orthopedic procedures, with capacity for as many as 20,000 more publicly funded surgeries.

Patients receiving insured procedures at those centres do not pay the clinic for the insured service. The province does.

That is private delivery with public financing.

It is a fundamentally different policy from a patient paying privately to move ahead of the public queue.

Confusing those two arrangements makes the Canadian debate much harder to understand.

Can a Canadian Simply Pay to Skip the Line?

Mostly not for publicly insured services, although the precise answer depends on the province and the service.

Take an MRI.

Private-pay diagnostic clinics have operated in several provinces, but Ottawa considers medically necessary MRI and CT imaging to be insured services under its Diagnostic Services Policy. When provinces allow patients to be charged for services Ottawa considers insured, the federal government can deduct equivalent amounts from the Canada Health Transfer.

In March 2023, Health Canada announced more than CAD 82 million in deductions, including CAD 76.4 million associated with patient charges for diagnostic services. In March 2024, it announced more than CAD 72 million in deductions associated with diagnostic charges while reimbursing more than CAD 83 million to provinces that had taken steps to eliminate charges.

Now take a hip or knee replacement.

Private facilities can perform publicly funded joint replacements. That does not mean a patient can simply write a cheque and buy an earlier place in the publicly insured queue. Direct private payment for medically necessary surgery remains much more restricted.

Quebec has a larger opted-out physician sector than the other provinces, and RAMQ maintains a current public list of non-participating and opted-out health professionals. Alberta is now beginning a distinct dual-practice experiment. British Columbia’s restrictions survived the lengthy Cambie constitutional challenge.

Specialist consultations follow the same general logic. An enrolled physician normally cannot charge a patient privately for a faster version of an insured physician consultation.

Executive medicine operates within another boundary. Clinics can charge for uninsured services, convenience services, assessments and testing that fall outside provincial insurance. They cannot simply convert an insured physician service into a privately billable service by changing the label.

And here is the oddity.

A Canadian who faces restrictions on privately purchasing a medically necessary insured service at home is generally free to travel to the United States, Mexico, Europe or elsewhere and purchase care privately. Provincial reimbursement for non-emergency out-of-country care is much more limited and typically requires prior approval, but Canadians are not prohibited from purchasing healthcare abroad with their own money.

Anyone seriously considering that route should treat provider selection as its own due-diligence exercise; I built a separate medical tourism due-diligence framework for evaluating foreign hospitals, clinics and doctors.

That does not prove Canada should permit the same transaction domestically. It does illustrate how unusual the Canadian financing restrictions can look from the patient’s perspective.

Chaoulli, Cambie and the Legal Battle Over Two-Tier Care

Two court cases frame much of the argument.

In Chaoulli v. Quebec, decided in June 2005, physician Jacques Chaoulli and patient George Zeliotis challenged Quebec’s restrictions on private insurance for publicly insured services in the context of long public waiting times.

The Supreme Court of Canada ruled 4–3 that the restrictions violated the Quebec Charter. The judges did not produce a majority ruling that the Canadian Charter required the same result nationwide, so the practical effect was centered on Quebec.

Quebec subsequently created a framework permitting private insurance for certain services and has continued to allow physicians to practise outside the public plan under specified conditions.

Quebec therefore has a meaningful sector of physicians who practise outside RAMQ. RAMQ maintains a public list of non-participating and opted-out professionals, rather than requiring estimates from secondary sources.

In the Cambie litigation, Dr. Brian Day and other plaintiffs challenged British Columbia restrictions on extra-billing, private billing by enrolled doctors and duplicate private insurance. Their argument was that the combination of long public waits and restrictions on private alternatives violated patients’ Charter rights.

The BC Supreme Court heard extensive evidence and accepted that some patients suffer harm while waiting. It nevertheless upheld the challenged provisions. The BC Court of Appeal dismissed the appeal in 2022.

On April 6, 2023, the Supreme Court of Canada dismissed the application for leave to appeal.

That distinction matters. The Supreme Court did not issue a new nationwide merits judgment endorsing or rejecting a parallel private system. It declined to hear the appeal, leaving the British Columbia Court of Appeal decision in place.

Neither Chaoulli nor Cambie is as simple as its reputation. The courts recognized that excessive waits can harm patients. They did not establish a general Canadian constitutional right to buy parallel private insurance.

Alberta Is Now Testing a Different Model

Alberta is running one of the country’s most consequential current experiments in private financing of medically necessary care.

Bill 11, the Health Statutes Amendment Act, 2025 (No. 2), passed the legislature in December 2025 and received royal assent on December 11, 2025.

The legislation creates a framework under which approved specialists can work in both public and private streams, with individual cases treated either publicly or privately.

As of the end of September 2026, Alberta says the dual-practice model is being implemented. Applications are open, approvals are being considered on a rolling basis, and the province says approved physicians are expected to begin practising under the model later in fall 2026.

Eligible areas include specified orthopedic surgery, cataract surgery and selected procedures in several other surgical specialties. Alberta says physicians participating in dual practice must maintain required public-service volumes, while emergency, urgent and life-threatening care — including cancer surgery — remains entirely publicly funded.

The Alberta government’s position is that the model complies with the Canada Health Act.

Critics disagree. A legal opinion prepared for the Canadian Health Coalition argues that the framework conflicts with federal medicare rules.

Those are competing legal interpretations. As of late September 2026, I found no federal determination declaring Bill 11 non-compliant, no court judgment resolving the issue and no Canada Health Transfer deduction imposed specifically because of Bill 11.

The legal question therefore remains unresolved, and the model is too new to judge from outcomes.

Why Canadians Defended This Model So Fiercely

None of this is about ignorance.

The commitment to medicare has deep historical roots. Saskatchewan introduced provincial hospital insurance in 1947 and physician insurance in 1962. Federal hospital-insurance legislation followed in 1957 and medical-care legislation in 1966. The Canada Health Act consolidated the federal conditions surrounding provincial medicare in 1984.

Over decades, medicare became more than a government program. It became a political symbol and part of Canadian national identity, particularly as a contrast with the United States.

That history helps explain why debates about financing and delivery can become emotionally charged.

But there is an important limit to what can be claimed about public perception.

I could not find credible polling that directly asks Canadians where they believe Canada’s healthcare system ranks globally. So the common assertion that Canadians falsely believe Canada has one of the world’s best healthcare systems cannot be demonstrated from the polling I found.

The polling that does exist points instead to considerable dissatisfaction.

In an Angus Reid Institute and Canadian Medical Association survey, 26% rated the system excellent or very good in 2023, down from 48% in 2015. In an Angus Reid poll released in 2026, 70% said their provincial healthcare system had deteriorated over the previous decade.

At the same time, polling has continued to show caution toward expanding private payment.

Those positions are not contradictory.

A person can strongly support universal access, believe the current system is performing badly and still distrust proposed alternatives.

“Free Healthcare” Is the Wrong Phrase

Healthcare in Canada is not free. It is prepaid collectively, mostly through taxation and government revenue, while households and insurers pay the remaining private share.

Total health spending is about CAD 9,626 per person in CIHI’s 2025 projection, and governments finance roughly 71% of the total.

The Fraser Institute, a market-oriented think tank, tries to estimate the implicit tax burden attributable to public healthcare.

Its 2026 edition estimates that an average two-parent, two-child family bears about CAD 21,115 of taxes allocated to public healthcare in 2026. Across six common household types, its estimates range from CAD 6,464 to CAD 21,115.

That number requires an important qualification.

It is not a healthcare premium.

No average family receives a CAD 21,115 healthcare invoice.

Fraser estimates the overall tax burden for different household types and then allocates part of those taxes to healthcare according to governments’ healthcare share of revenue. Because Canada’s tax system is progressive, the estimated burden differs dramatically by income.

The calculation is useful mainly as a reminder of how public healthcare is financed.

“Free healthcare” means the patient is usually not charged when receiving an insured service. It does not mean the system has no cost.

Some healthcare costs that Canadians do pay personally may also interact with the Canada Medical Expense Tax Credit, which is worth understanding separately from how the healthcare system itself is financed.

So Is Canadian Healthcare World Class?

The evidence looks very different depending on the dimension being measured.

Financial protection and universal core coverage are major strengths. Canadians have broad protection from catastrophic bills for medically necessary hospital and physician care. Canada also performs better than the OECD average on several major outcome indicators, including treatable mortality.

Access and timeliness are persistent weaknesses. Canada performs poorly in several international comparisons of primary-care access, same-/next-day care and specialist access. Domestic administrative data also show substantial waits for elective procedures and hospital admission.

Capacity presents a mixed but concerning picture. Canada has fewer physicians, hospital beds and major diagnostic scanners per capita than the OECD average, although the experience of Denmark, Sweden and the Netherlands shows that low bed numbers alone do not determine access.

Patient choice is more restricted than in many other universal systems. Canada uses extensive private delivery, but private financing of publicly insured hospital and physician services is much more constrained than in systems such as Australia, France, the Netherlands or Switzerland.

Outcomes remain comparatively respectable. Canada is not a country where healthcare routinely produces poor clinical results. Its difficulty is often timely entry into the care pathway rather than the quality of every service once treatment occurs.

That distinction is what gets lost when Canadian healthcare is reduced either to a national success story or to a system in collapse.

The more useful comparison is not simply Canada versus the United States.

It is Canada versus countries such as Denmark, Australia, the Netherlands, France and Norway — countries that also guarantee broad healthcare access while organizing financing, capacity and delivery in very different ways.

What Canada Could Learn

No single reform follows automatically from the international evidence. Every model carries trade-offs.

Still, several approaches used elsewhere are worth understanding.

Primary-care attachment. Norway operates a regular-GP system, and Denmark relies heavily on GP gatekeeping. Canadian provinces are moving toward team-based and alternative-payment models, but assigning or attaching patients to longitudinal primary care requires enough clinicians to make the promise meaningful.

Workforce and licensing. Expanding medical residency capacity, improving pathways for qualified internationally trained physicians and using nurse practitioners, pharmacists and other professionals more fully could expand effective capacity. Each option involves questions about training, standards, budgets and professional scope.

Hospital funding. Activity- or case-based funding pays providers for additional treated cases rather than relying solely on fixed global budgets. Several Canadian provinces use or are experimenting with versions of these models. They can create stronger volume incentives but also require safeguards against inappropriate activity or selection of easier patients.

Flow and discharge. Countries operating successfully with relatively few hospital beds often have stronger systems for rehabilitation, long-term care and home care. Expanding those services can release acute-care beds, but requires its own workforce and capital investment.

Diagnostics and operating hours. Canada has relatively low diagnostic-equipment density. Purchasing more machines only helps if the system can also staff and fund them for enough hours to expand throughput.

Waiting-time guarantees and central referral. Denmark and other European systems use formal patient-choice or waiting-time mechanisms. Centralized referral systems can also allow patients to take the first available qualified provider rather than remaining attached to one specialist’s queue. Such guarantees work only when underlying capacity exists.

Publicly funded private delivery. Canada already does this. Ontario and Quebec purchase surgeries and diagnostics from independently operated clinics, and other provinces contract with private facilities as well. The relevant policy question is not whether private providers exist, but how they are paid, regulated and integrated with the public system.

Structured private financing. Australia, France, the Netherlands and Switzerland demonstrate that universal access can coexist with much larger roles for private insurance or direct payment than Canada permits. Their experience also shows trade-offs involving cost sharing, equity, administrative complexity and workforce distribution.

The international evidence does not establish one correct model for Canada.

What it does establish is something more basic: universal coverage and Canada’s current institutional arrangements are not the same thing.

Universal access is an objective.

How a country finances insurance, pays hospitals, organizes primary care, licenses professionals, purchases diagnostics and uses private providers are design choices layered on top of that objective.

Canada’s model deserves to be judged the same way any other system should be judged: by what it costs, whom it protects, how quickly patients can get care and what happens to them when they do.